Skip to content
Preprint

Threshold Geometry, Bifurcation, and Data-Driven Analysis of a Vaccination-Treatment Model for Hepatitis B

Sep 2026 · 0 citations · 38 references
Mathematics

Abstract

Despite the availability of excellent vaccines and antiviral medicines, hepatitis B virus (HBV) remains a major public health problem. In this work, we develop a mathematical vaccination-treatment model for HBV transmission to investigate threshold conditions for illness persistence as well as the level of intervention. The analysis gives the characterisation of both disease-free and endemic equilibria and determines the basic reproduction number, $\mathcal{R}_0$, by the next-generation matrix approach. The model indicates that $\mathcal{R}_0=1$ is a critical threshold dividing disease-free from endemic states and characterises a forward transcritical bifurcation regarding the transmission parameter. Numerical equilibrium continuation and stability assessments confirm the analytical results. A two-parameter study of transmission and vaccination rates identifies threshold geometries and assesses impacts of important parameters using sensitivity analysis. The model is calibrated with India-specific data, such as HBsAg prevalence, HBV incidence and mortality rates and fits epidemiological targets closely through limited nonlinear calibration. Additionally, multi-start optimisation and practical identifiability profiling are used to investigate parameter uncertainty. Robustness analyses reveal that the calibrated $\mathcal{R}_0^*=1.1744$ is associated with a super-threshold regime; however, parameter flexibility permits both sub-threshold and super-threshold regimes. This combined analytical and data-driven framework connects epidemic thresholds, bifurcation structures, intervention efficacy, and parameter uncertainty. It provides a quantitative framework for analysing HBV persistence and evaluating control options, especially in the absence of epidemiological evidence.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.